Open-angle glaucoma represents one of the most prevalent causes of irreversible sight loss globally. The principal aim of treatment is to lower intraocular pressure (IOP) to slow the progression of ...

Bimatoprost ophthalmic solution 0.01% is a prostaglandin analog indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Please provide your email address to receive an email when new articles are posted on . The safety and efficacy of selective laser trabeculoplasty was comparable to argon laser trabeculoplasty. Data ...

Please provide your email address to receive an email when new articles are posted on . Consider angle morphology when treating patients with neovascular glaucoma. Comparable visual acuity and IOP and ...

India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has received clearance from the U.S. Food and Drug Administration (FDA)-the ...

Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life threatening ...

A risk score incorporating genetic variants for open-angle glaucoma is accurate enough to help with diagnosis of the condition, an interim study reveals. Although hundreds of genetic changes are ...

Study finds that resident macrophages maintain eye pressure by clearing buildup in drainage tissues. Their loss increases ...

A trio of ASCRS presentations collectively offer insight to surgeons, suggesting that glaucoma drops harm meibomian glands, ...

Glaucoma is not fatal. Without treatment, glaucoma can cause significant vision loss and eventually blindness, but early treatment can help protect vision and slow the progression of the disease.